Prescribing
US$ 21.33
long-term effects of glp-1 receptor agonists Success GLP-1s Hinges on More Than Just a Prescription Clinical Recommendations to Manage Gastrointestinal
Description
Mounjaro and its alternatives all contain tirzepatide, the dual GIP/GLP-1 receptor agonist that produces exceptional weight loss results
Victoza (the diabetes formulation) typically has better coverage
None of the above-mentioned companies had any role in the preparation of this paper, which has been written independently and without any financial or professional help
[DOI] [PubMed] [Google Scholar] 99.Linnebjerg H, Seger M, Kothare PA, Hunt T, Wolka AM, Mitchell MI
[DOI] [PubMed] [Google Scholar] 37
